• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中内脏脂肪堆积的代谢效应

Metabolic effects of visceral fat accumulation in type 2 diabetes.

作者信息

Gastaldelli Amalia, Miyazaki Yoshinori, Pettiti Maura, Matsuda Masafumi, Mahankali Srihanth, Santini Eleonora, DeFronzo Ralph A, Ferrannini Ele

机构信息

Metabolism Unit, Department of Internal Medicine, University of Pisa, Via Savi, I-56100 Pisa, Italy.

出版信息

J Clin Endocrinol Metab. 2002 Nov;87(11):5098-103. doi: 10.1210/jc.2002-020696.

DOI:10.1210/jc.2002-020696
PMID:12414878
Abstract

Visceral fat (VF) excess has been associated with decreased peripheral insulin sensitivity and has been suggested to contribute to hepatic insulin resistance. However, the mechanisms by which VF impacts on hepatic glucose metabolism and the quantitative role of VF in glycemic control have not been investigated. In the present study 63 type 2 diabetic subjects (age, 55 +/- 1 yr; fasting plasma glucose, 5.5-14.4 mmol/liter; hemoglobin A(1c), 6.1-11.7%) underwent measurement of 1) fat-free mass ((3)H(2)O technique), 2) sc and visceral abdominal fat area (magnetic resonance imaging), 3) insulin sensitivity (euglycemic insulin clamp), 4) endogenous glucose output ([(3)H]glucose infusion technique), and 5) gluconeogenesis ((2)H(2)O method). After adjustment for sex, age, body mass index, diabetes duration, ethnicity, and sc fat area, VF area was positively related to fasting hyperglycemia (partial r = 0.46; P = 0.001) as well as to hemoglobin A(1c) (partial r = 0.50; P = 0.0003). Insulin sensitivity was reciprocally related to VF independently of body mass index (partial r = 0.33; P = 0.01). In contrast, the relation of basal endogenous glucose output to VF was not statistically significant. This lack of association was explained by the fact that VF was positively associated with gluconeogenesis flux (confounder-adjusted, partial r = 0.45; P = 0.003), but was reciprocally associated with glycogenolysis (partial r = 0.31; P < 0.05). We conclude that in patients with established type 2 diabetes, VF accumulation has a significant negative impact on glycemic control through a decrease in peripheral insulin sensitivity and an enhancement of gluconeogenesis.

摘要

内脏脂肪(VF)过多与外周胰岛素敏感性降低有关,并被认为会导致肝脏胰岛素抵抗。然而,VF影响肝脏葡萄糖代谢的机制以及VF在血糖控制中的定量作用尚未得到研究。在本研究中,63名2型糖尿病患者(年龄55±1岁;空腹血糖5.5 - 14.4 mmol/升;糖化血红蛋白6.1 - 11.7%)接受了以下测量:1)去脂体重((3)H(2)O技术),2)皮下和内脏腹部脂肪面积(磁共振成像),3)胰岛素敏感性(正常血糖胰岛素钳夹),4)内源性葡萄糖生成((3)H葡萄糖输注技术),以及5)糖异生((2)H(2)O方法)。在对性别、年龄、体重指数、糖尿病病程、种族和皮下脂肪面积进行调整后,VF面积与空腹高血糖呈正相关(偏相关系数r = 0.46;P = 0.001),与糖化血红蛋白也呈正相关(偏相关系数r = 0.50;P = 0.0003)。胰岛素敏感性与VF呈负相关,且独立于体重指数(偏相关系数r = 0.33;P = 0.01)。相比之下,基础内源性葡萄糖生成与VF的关系无统计学意义。这种缺乏关联的情况可以通过以下事实来解释:VF与糖异生通量呈正相关(经混杂因素调整后,偏相关系数r = 0.45;P = 0.003),但与糖原分解呈负相关(偏相关系数r = 0.31;P < 0.05)。我们得出结论,在已确诊的2型糖尿病患者中,VF堆积通过降低外周胰岛素敏感性和增强糖异生对血糖控制产生显著负面影响。

相似文献

1
Metabolic effects of visceral fat accumulation in type 2 diabetes.2型糖尿病中内脏脂肪堆积的代谢效应
J Clin Endocrinol Metab. 2002 Nov;87(11):5098-103. doi: 10.1210/jc.2002-020696.
2
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.2型糖尿病患者的腹部脂肪分布与外周及肝脏胰岛素抵抗
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001.
3
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.吡格列酮对2型糖尿病患者腹部脂肪分布及胰岛素敏感性的影响。
J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91. doi: 10.1210/jcem.87.6.8567.
4
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.非糖尿病和2型糖尿病患者肝脏/内脏脂肪与肝脏胰岛素抵抗之间的关系。
Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1.
5
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.在接受吡格列酮治疗的2型糖尿病患者中,血浆脂联素浓度降低与肝脏脂肪含量及肝脏胰岛素抵抗密切相关。
J Clin Endocrinol Metab. 2004 Jan;89(1):200-6. doi: 10.1210/jc.2003-031315.
6
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.生理性高胰岛素血症对非糖尿病受试者及2型糖尿病患者糖异生的影响。
Diabetes. 2001 Aug;50(8):1807-12. doi: 10.2337/diabetes.50.8.1807.
7
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.肥胖和2型糖尿病对人体糖异生和葡萄糖生成的影响:一项定量研究。
Diabetes. 2000 Aug;49(8):1367-73. doi: 10.2337/diabetes.49.8.1367.
8
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.吡格列酮可降低2型糖尿病患者的肝脏脂肪含量并增加内脏葡萄糖摄取。
Diabetes. 2003 Jun;52(6):1364-70. doi: 10.2337/diabetes.52.6.1364.
9
Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.无论体型如何,男性2型糖尿病患者内脏脂肪的主要分布与肝脏胰岛素抵抗密切相关。
Cardiovasc Diabetol. 2009 Aug 5;8:44. doi: 10.1186/1475-2840-8-44.
10
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.二甲双胍和罗格列酮单药治疗对2型糖尿病患者胰岛素介导的肝脏葡萄糖摄取的影响及其与内脏脂肪的关系。
Diabetes Care. 2003 Jul;26(7):2069-74. doi: 10.2337/diacare.26.7.2069.

引用本文的文献

1
Differential associations of subcutaneous and visceral fat with bone turnover markers: A study on bariatric surgery patients with severe obesity and individuals without obesity.皮下脂肪和内脏脂肪与骨转换标志物的差异关联:一项针对重度肥胖的减肥手术患者和非肥胖个体的研究。
Int J Obes (Lond). 2025 Aug 26. doi: 10.1038/s41366-025-01888-1.
2
Mobile Health Interventions for Individuals with Type 2 Diabetes and Overweight or Obesity-A Systematic Review and Meta-Analysis.2型糖尿病合并超重或肥胖个体的移动健康干预措施——一项系统评价与Meta分析
J Funct Morphol Kinesiol. 2025 Jul 29;10(3):292. doi: 10.3390/jfmk10030292.
3
Metabolic Signalling Peptides and Their Relation to Clinical and Demographic Characteristics in Acute and Recovered Females with Anorexia Nervosa.
代谢信号肽及其与急性和康复期神经性厌食症女性临床及人口统计学特征的关系
Nutrients. 2025 Apr 14;17(8):1341. doi: 10.3390/nu17081341.
4
Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.达格列净在血糖控制和体重减轻方面的反应差异。
Endocrinol Metab (Seoul). 2025 Apr;40(2):278-288. doi: 10.3803/EnM.2024.2142. Epub 2025 Mar 19.
5
Preliminary quantitative analysis of renal sinus fat dysfunction in T2DM patients using MRI fat fraction and R2* mapping.利用MRI脂肪分数和R2* 成像对2型糖尿病患者肾窦脂肪功能障碍进行初步定量分析。
Front Endocrinol (Lausanne). 2025 Feb 19;16:1486839. doi: 10.3389/fendo.2025.1486839. eCollection 2025.
6
The Metabolic Score for Visceral Fat (METS-VF) as a predictor of diabetes mellitus: Evidence from the 2011-2018 NHANES study.内脏脂肪代谢评分(METS-VF)作为糖尿病的预测指标:来自2011 - 2018年美国国家健康与营养检查调查(NHANES)研究的证据。
PLoS One. 2025 Feb 11;20(2):e0317913. doi: 10.1371/journal.pone.0317913. eCollection 2025.
7
Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort.“展望”队列中肥胖程度降低与糖化血红蛋白水平降低及胰岛素使用减少之间的关联。
Obesity (Silver Spring). 2025 Mar;33(3):612-620. doi: 10.1002/oby.24242. Epub 2025 Feb 4.
8
Osteoporosis as the Female-Specific Risk Factor for Dynapenia in Elderly Patients with Type 2 Diabetes.骨质疏松症作为老年2型糖尿病患者肌肉减少症的女性特异性危险因素。
J Clin Med. 2024 Aug 6;13(16):4590. doi: 10.3390/jcm13164590.
9
Association of Visceral Adiposity Index and Handgrip Strength with Cardiometabolic Multimorbidity among Middle-Aged and Older Adults: Findings from Charls 2011-2020.内脏脂肪指数与握力与中老年人心血管代谢性多种疾病的相关性:来自 CHARLS 2011-2020 年的研究结果。
Nutrients. 2024 Jul 15;16(14):2277. doi: 10.3390/nu16142277.
10
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes.内脏脂肪组织:2 型糖尿病的幕后黑手。
Nutrients. 2024 Mar 30;16(7):1015. doi: 10.3390/nu16071015.